Gainers
- Aeglea BioTherapeutics (NASDAQ:AGLE) shares rose 53.4% to $0.87 during Friday's regular session. Trading volume for this security as of 13:30 EST is 25.1 million, which is 1291.9% of its average full-day volume over the last 100 days. The company's market cap stands at $53.4 million.
- Nuvalent (NASDAQ:NUVL) stock rose 50.56% to $33.12. As of 13:30 EST, this security is trading at a volume of 3.6 million shares, making up 2613.8% of its average full-day volume over the last 100 days. The company's market cap stands at $1.6 billion.
- Biotricity (NASDAQ:BTCY) shares increased by 20.05% to $1.49. As of 13:30 EST, this security is trading at a volume of 622.3K shares, making up 326.4% of its average full-day volume over the last 100 days. The company's market cap stands at $77.2 million.
- NGM Biopharmaceuticals (NASDAQ:NGM) stock rose 18.2% to $5.65. As of 13:30 EST, this security is trading at a volume of 894.7K shares, making up 101.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $454.0 million.
- Scholar Rock Holding (NASDAQ:SRRK) stock increased by 17.95% to $9.13. As of 13:30 EST, Scholar Rock Holding's stock is trading at a volume of 194.3K, which is 65.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $471.4 million.
- DexCom (NASDAQ:DXCM) shares increased by 16.23% to $117.69. As of 13:30 EST, this security is trading at a volume of 4.7 million shares, making up 168.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.8 billion. As per the press release, Q3 earnings came out yesterday.
Losers
- DaVita (NYSE:DVA) shares declined by 28.0% to $69.64 during Friday's regular session. As of 13:30 EST, this security is trading at a volume of 3.3 million shares, making up 473.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.3 billion. The company's, Q3 earnings came out today.
- LeMaitre Vascular (NASDAQ:LMAT) shares decreased by 17.63% to $42.7. Trading volume for LeMaitre Vascular's stock is 289.5K as of 13:30 EST. This is 309.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $937.7 million. As per the press release, Q3 earnings came out yesterday.
- PhaseBio Pharmaceuticals (NASDAQ:PHAS) shares decreased by 17.53% to $0.11. As of 13:30 EST, this security is trading at a volume of 2.9 million shares, making up 342.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.4 million.
- Edwards Lifesciences (NYSE:EW) stock decreased by 16.51% to $72.06. As of 13:30 EST, this security is trading at a volume of 10.9 million shares, making up 390.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $44.6 billion. As per the news, the Q3 earnings report came out yesterday.
- Kazia Therapeutics (NASDAQ:KZIA) stock fell 16.17% to $0.83. As of 13:30 EST, this security is trading at a volume of 962.6K shares, making up 173.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.5 million.
- Decibel Therapeutics (NASDAQ:DBTX) stock declined by 15.05% to $3.5. Trading volume for this security as of 13:30 EST is 66.3K, which is 115.8% of its average full-day volume over the last 100 days. The company's market cap stands at $87.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
